Abstract Background: GLP-1 receptor agonists (GLP-1RAs) address key metabolic drivers of Polycystic Ovary Syndrome (PCOS), yet their integration into fertility management remains challenging because reproductive efficacy is variably reported, preconception washout is required, and standardized clinical pathways are lacking
These recommendations are designed to help you meet your nutritional needs, preserve muscle mass, and minimise common side effects while eating less overall
has also received CME-related honoraria or consulting fees from CASEN Recordati, Organon, Lundbeck, and the Academy for Continuing Medical Education (Akademijazakme), with no financial or other conflicts of interest relevant to the subject of this article
Liquid SLU-PP-332 is listed for professional research use with an emphasis on documentation, compound identification, research applications, storage awareness, and third-party testing transparency
The FDA will likely increase enforcement against vendors selling unapproved retatrutide, and the market may contract significantly